Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04074343
Title TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Irvine
Indications

gastroesophageal cancer

gastric adenocarcinoma

Therapies

Irinotecan + Trifluridine-tipiracil hydrochloride

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.